IFNG and neoplasm: Given that not all individual cancer cells in human tumours are unresponsive to IFNγ, we used a B16-OVA WT and IFNγRKO admix model whereby tumour cells are tagged in ZsGreen or mCherry, or vice versa, and mixed in equal proportions prior to engraftment (Fig. 2E).